Zen-Bio, Inc. Awarded Grant to Provide Human Breast Cancer Cell System
Published: Sep 16, 2008
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ZenBio, Inc., a privately held biotechnology company, announced that it has been awarded a Phase I SBIR grant to provide a unique human primary cell system for breast cancer research. The $200,000 award from the National Institutes of Health will fund the isolation and culturing of primary human basal and luminal mammary ductal cells for the development of a donor-matched cell system.